Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125624172 | 12562417 | 2 | F | 20160823 | 20160715 | 20160829 | EXP | JP-PFIZER INC-2016344704 | PFIZER | FUJII, K.. ADRENAL INSUFFICIENCY UNDER STANDARD DOSAGE OF GLUCOCORTICOID REPLACEMENT AFTER UNILATERAL ADRENALECTOMY FOR CUSHING^S SYNDROME.. CASE REPORTS IN ENDOCRINOLOGY. 2016;2016:10.1155/2016/2347528 | 62.00 | YR | F | Y | 0.00000 | 20160829 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125624172 | 12562417 | 1 | PS | HYDROCORTISONE. | HYDROCORTISONE | 1 | 200 MG, DAILY | Y | 8697 | 200 | MG | ||||||||
| 125624172 | 12562417 | 2 | SS | HYDROCORTISONE. | HYDROCORTISONE | 1 | Intravenous (not otherwise specified) | 200 MG, UNK | Y | 8697 | 200 | MG | |||||||
| 125624172 | 12562417 | 3 | SS | HYDROCORTISONE. | HYDROCORTISONE | 1 | Oral | 30 MG, DAILY | Y | 8697 | 30 | MG | |||||||
| 125624172 | 12562417 | 4 | C | FUROSEMIDE. | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 125624172 | 12562417 | 5 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | UNK | 0 | |||||||||||
| 125624172 | 12562417 | 6 | C | BISOPROLOL | BISOPROLOL | 1 | UNK | 0 | |||||||||||
| 125624172 | 12562417 | 7 | C | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 125624172 | 12562417 | 8 | C | CIBENZOLINE | CIFENLINE | 1 | UNK | 0 | |||||||||||
| 125624172 | 12562417 | 9 | C | LOVASTATIN. | LOVASTATIN | 1 | UNK | 0 | |||||||||||
| 125624172 | 12562417 | 10 | C | ENTECAVIR. | ENTECAVIR | 1 | UNK | 0 | |||||||||||
| 125624172 | 12562417 | 11 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | 8 MG, UNK | 0 | 8 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125624172 | 12562417 | 4 | Fluid retention |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125624172 | 12562417 | OT |
| 125624172 | 12562417 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125624172 | 12562417 | Adrenal insufficiency | |
| 125624172 | 12562417 | Cushing's syndrome | |
| 125624172 | 12562417 | Decreased appetite | |
| 125624172 | 12562417 | Fatigue | |
| 125624172 | 12562417 | Malabsorption | |
| 125624172 | 12562417 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |